Note: only publications that have been accepted are shown.

  1. P. Meysman, B. Ogunjimi, S. Naulaerts, P. Beutels, V. Van Tendeloo and K. Laukens. Varicella-zoster virus-derived MHC class I-restricted peptide affinity is a determining factor for HLA risk profile to develop PHN. Journal of Virology, 2015, 15;89(2):962-9. 
  2. P. Meysman, D. Federov, V. Van Tendeloo, B. Ogunjimi and K. Laukens. Immunological evasion of immediate-early varicella zoster virus proteins. Immunogenetics, 2016, Jul;68(6-7):483-6.
  3. B. Ogunjimi, J. Van den Bergh*, P. Meysman*, S. Heynderickx , K. Bergs , H. Jansens , E. Leuridan , A. Vorsters , H. Goossens , K. Laukens , N. Cools , V. Van Tendeloo , N. Hens , P. Van Damme , E. Smits**  and P. Beutels**. *equal contribution, **equal contribution. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Scientific Reports, 2017, Apr 24;7(1):1077.
  4. B. Ogunjimi*, S. Y . Zhang*, K. Sorenson*, K. Skipper , M. Carter - Timofte, G. K erner , S. Lucke, T . Prabakaran, Y . Cai, J. Meester , E. Bartholomeus, N. Ajit Bolar , G. V andeweyer , C. Claes, Y . Sillis, L. Lorenzo, R. Fiorenza, S. Boucherit, C. Dielman, Steven Heynderickx, G. Elias, A. Kurotova, A. Vander Auwera, L. Verstraete, L. Lagae, H. Verhelst, A. Jansen, J. Ramet, A. Suls, E. Smits, B. Ceulemans, L. Van Laer , G. Plat Wilson, J. Kreth, C. Picard, H. V on Bernuth, J. Fluss, S. Chabrier , L. Abel, G. Mortier, S. Fribourg, J. Giehm Mikkelsen, J.L. Casanova, S.R Paludan and T.H. Mogensen. *equal contribution. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. Journal of Clinical Investigation, 2017, Aug 7.
  5. N. De Neuter, C. Beirnaert, W. Bittremieux, B. Cuypers, A. Ligata, P. Moris, A. Suls, V. Van Tendeloo, B. Ogunjimi, K. Laukens* and P. Meysman*. *equal contribution. On the feasibility of mining CD8+ T-cell receptor patterns underlying immunogenic peptide recognition. Immunogenetics, 2018, 70(3):159-168.
  6. P. Meysman, N. De Neuter, E. Bartholomeus, G. Elias, J. Van den Bergh, M.P. Emonds, G.W. Haasnoot, S. Heynderickx, J. Wens, N.R. Michels, J. Lambert, E. Lion, F.H.J. Claas, H. Goossens, E. Smits, P. Van Damme, V. Van Tendeloo, P. Beutels, A. Suls, G. Mortier, K. Laukens* and B. Ogunjimi*. *equal contribution. Increased herpes zoster risk associated with poor HLA-A Immediate Early 62 Protein (IE62) affinity. Immunogenetics, 2018, 70(6):363-372.
  7. N. De Neuter, E. Bartholomeus, G. Elias, N. Keersmaekers, A. Suls, H. Jansens, E. Smits, N. Hens, P. Beutels, P. Van Damme, G. Mortier, V. Van Tendeloo, K. Laukens, P. Meysman* and B. Ogunjimi*. *equal contribution. Memory CD4+ T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus. Genes and Immunity, in press. 
  8. G. Elias, A. Souquette, S. Heynderickx, I. De Meester, H. Jansens, P. Beutels, P. Van Damme, E. Smits, P. Thomas, V. Van Tendeloo and B. Ogunjimi. Altered CD4+ T-Cell Immunity in Nurses Occupationally Exposed to Viral Pathogens. Clinical and Experimental Immunology, in press.
  9. E. Bartholomeus*, N. De Neuter*, P. Meysman, A. Suls, N. Keersmaekers, G. Elias, H. Jansens, N. Hens, E. Smits, V. Van Tendeloo, P. Beutels, P. Van Damme, B. Ogunjimi**, K. Laukens** and G. Mortier**. *equal contribution, **equal contribution. Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders. Vaccine, accepted.
  10. P. Meysman, N. De Neuter, S. Gielis, D. Bui Thi, B. Ogunjimi and K. Laukens. On the viability of unsupervised T-cell receptor sequence clustering for epitope preference. Bioinformatics, accepted.


On bioRxiv

  1. S. Gielis, P. Moris, N. De Neuter, W. Bittremieux, B. Ogunjimi, K. Laukens and P. Meysman.  TCRex: a webtool for the prediction of T-cell receptor sequence epitope specificity.


Editorials or commentaries on publications

About Ogunjimi et al, Journal of Clinical Investigation, 2017: J. Miner. Deterring zoster. Science Translational Medicine, 2017, 30 Aug.